4.5 Article

Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities- surveillance results from southern Sweden, July 2021 to January 2022

Journal

EUROSURVEILLANCE
Volume 27, Issue 9, Pages -

Publisher

EUR CENTRE DIS PREVENTION & CONTROL
DOI: 10.2807/1560-7917.ES.2022.27.9.2200121

Keywords

-

Funding

  1. Swedish Research Council (VR) [2019-00198, 2021-04665]
  2. Sweden's Innovation Agency (Vinnova) [2021-02648]
  3. Lund University
  4. Swedish Research Council
  5. Governmental Funds for Clinical Research (ALF)
  6. Swedish Research Council for Health, Working life and Welfare (Forte) [2020-00962]
  7. Formas [2020-00962] Funding Source: Formas
  8. Forte [2020-00962] Funding Source: Forte
  9. Swedish Research Council [2021-04665] Funding Source: Swedish Research Council

Ask authors/readers for more resources

We compared the risk of severe COVID-19 between the periods of 2021 and 2022 in Scania county, Sweden, when Delta and Omicron were the dominant virus variants. Adjusting for factors like sex, age, comorbidities, prior infection, and vaccination, we found that the risk of severe disease from Omicron was significantly lower among vaccinated cases. It was also lower among the unvaccinated population, but remained high (> 5%) for older individuals and middle-aged men with multiple comorbidities. Efforts to increase vaccination uptake should continue.
We compared the risk of severe COVID-19 during two periods 2021 and 2022 when Delta and Omicron, respectively, were the dominating virus variants in Scania county, Sweden. We adjusted for differences in sex, age, comorbidities, prior infection and vaccina-tion. Risk of severe disease from Omicron was mark-edly lower among vaccinated cases. It was also lower among the unvaccinated but remained high (> 5%) for older people and middle-aged men with two or more comorbidities. Efforts to increase vaccination uptake should continue.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available